Table 3 Time-to-progression after systemic therapy
Line of treatment | Median time-to-progression (months) |
|---|---|
First (n = 38) | 3.9 (range 0.6 to 33.7) |
Second (n = 23) | 2.3 (range 0.3 to 13.9) |
Third (n = 13) | 1.1 (range 0.6 to 11.8) |
Line of treatment | Median time-to-progression (months) |
|---|---|
First (n = 38) | 3.9 (range 0.6 to 33.7) |
Second (n = 23) | 2.3 (range 0.3 to 13.9) |
Third (n = 13) | 1.1 (range 0.6 to 11.8) |
Clinical Sarcoma Research